Stock investors may look back at 2025 as the year of the takeover — one that delivered sizeable gains. “It’s going to be a ...
Tonix Pharmaceuticals (NASDAQ: TNXP) released selected preliminary financial results for 2024, reporting approximately $98.8 million in cash and cas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback